From IV hydration to mental health support, the clinic is devoted to helping the community live better, one patient at a time ...

Clinical stage biotech Tryptamine Therapeutics has achieved a major milestone in the development of its novel IV-infused ...

Special Report: Clinical-stage biotech Tryptamine Therapeutics has achieved a key milestone, successfully completing the ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life ...

IV drips for hangovers are becoming a flashy trend, but experts warn they may strain vital organs. While they might look ...

As we continually discover new ways to harness emerging AI technology, AI computing clusters are at the front end of a huge ...

Total Revenue -- $21.2 million for the third quarter of 2025, up 16%, driven by MRI compatible IV infusion pump and ...

On the left, a glossy chocolate mini cake topped with a decorative chocolate ring and a bright cherry — refined, shiny, and ...

The company is deeply embedded in hospital operations, with a large installed base of equipment and a broad consumables ...

Emera unveiled a $20B five-year capital plan, targeting 7-8% rate base growth and 5-7% adjusted EPS growth through 2027. Read ...